BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+95.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$4.87M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1
+$3.05M
2
+$2.52M
3
+$2.23M
4
RLMD icon
Relmada Therapeutics
RLMD
+$1.94M
5
CLDX icon
Celldex Therapeutics
CLDX
+$1.91M

Top Sells

1
+$3.6M
2
+$2.93M
3
+$2.22M
4
IMNM icon
Immunome
IMNM
+$1.78M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$1.77M

Sector Composition

1 Healthcare 73.14%
2 Technology 21.04%
3 Energy 4.89%
4 Materials 0.6%
5 Financials 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
26
Pacific Biosciences
PACB
$491M
$1.98M 1.13%
1,500,000
+1,000,000
CYTK icon
27
Cytokinetics
CYTK
$9.6B
$1.98M 1.13%
30,000
CORT icon
28
Corcept Therapeutics
CORT
$7.8B
$1.9M 1.08%
47,200
-20,000
VERA icon
29
Vera Therapeutics
VERA
$2.24B
$1.77M 1.01%
44,000
ALKS icon
30
Alkermes
ALKS
$7.13B
$1.77M 1.01%
50,000
ENGN icon
31
enGene Therapeutics
ENGN
$112M
$1.7M 0.97%
+250,000
QURE icon
32
uniQure
QURE
$1.88B
$1.65M 0.94%
100,697
+69,908
ZBIO
33
Zenas BioPharma
ZBIO
$1.08B
$1.37M 0.78%
+70,000
QDEL icon
34
QuidelOrtho
QDEL
$927M
$1.36M 0.77%
82,548
+10,000
FHTX icon
35
Foghorn Therapeutics
FHTX
$213M
$1.35M 0.77%
281,730
RARE icon
36
Ultragenyx Pharmaceutical
RARE
$2.21B
$1.3M 0.74%
62,000
XENE icon
37
Xenon Pharmaceuticals
XENE
$5.17B
$1.22M 0.7%
21,000
KALV icon
38
KalVista Pharmaceuticals
KALV
$1.43B
$1.15M 0.65%
57,000
IMNM icon
39
Immunome
IMNM
$2.19B
$1.09M 0.62%
50,000
-80,000
FCX icon
40
Freeport-McMoran
FCX
$102B
$1.06M 0.6%
18,040
-6
AXSM icon
41
Axsome Therapeutics
AXSM
$11.4B
$1.01M 0.58%
6,000
-61
BIIB icon
42
Biogen
BIIB
$27.9B
$917K 0.52%
+5,000
LPCN icon
43
Lipocine
LPCN
$18.1M
$893K 0.51%
+111,786
TVTX icon
44
Travere Therapeutics
TVTX
$4.2B
$868K 0.49%
29,200
-13,800
HROW icon
45
Harrow
HROW
$1.24B
$846K 0.48%
24,000
-10,000
PHVS icon
46
Pharvaris
PHVS
$2.03B
$843K 0.48%
29,847
VSTM icon
47
Verastem
VSTM
$318M
$795K 0.45%
150,000
APGE icon
48
Apogee Therapeutics
APGE
$6.35B
$758K 0.43%
9,000
-7,000
HALO icon
49
Halozyme
HALO
$7.86B
$653K 0.37%
10,100
BBIO icon
50
BridgeBio Pharma
BBIO
$12.5B
$645K 0.37%
8,688
1
2
3 4